SOPHIA PEREZ-HEYDRICH: Open Payments
NPI 1326702903 · SOUTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,983 in 158 payments from 23 companies in 2025. Trend: 2023 $2,875 · 2024 $3,684 · 2025 $2,983
Food & beverage: $2,983
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 28 | $549 |
| UCB, Inc. | 28 | $398 |
| ABBVIE INC. | 22 | $356 |
| Janssen Biotech, Inc. | 14 | $298 |
| Novartis Pharmaceuticals Corporation | 18 | $274 |
| ANI Pharmaceuticals, Inc. | 7 | $136 |
| GlaxoSmithKline, LLC. | 6 | $125 |
| GENZYME CORPORATION | 4 | $114 |
| Aurinia Pharma U.S., Inc. | 4 | $100 |
| Radius Health, Inc. | 5 | $99 |
Products named: Bimzelx, TREMFYA, COSENTYX, SKYRIZI, UPLIZNA, KRYSTEXXA, BENLYSTA, KEVZARA.
Industry payments across FL — which companies pay providers there.
